BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17603279)

  • 1. Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells.
    Lampiasi N; Azzolina A; Montalto G; Cervello M
    Exp Mol Med; 2007 Jun; 39(3):284-94. PubMed ID: 17603279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.
    Poma P; Notarbartolo M; Labbozzetta M; Sanguedolce R; Alaimo A; Carina V; Maurici A; Cusimano A; Cervello M; D'Alessandro N
    Int J Oncol; 2006 Apr; 28(4):923-30. PubMed ID: 16525642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
    Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
    Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation.
    Wang SY; Chen LY; Tsai TF; Su TS; Choo KB; Ho CK
    Exp Hematol; 1996 Feb; 24(3):437-44. PubMed ID: 8599973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma.
    Labbozzetta M; Notarbartolo M; Poma P; Giannitrapani L; Cervello M; Montalto G; D'Alessandro N
    Ann N Y Acad Sci; 2006 Nov; 1089():268-75. PubMed ID: 17261774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.
    Lampiasi N; Azzolina A; Umezawa K; Montalto G; McCubrey JA; Cervello M
    Cancer Lett; 2012 Sep; 322(1):35-44. PubMed ID: 22343223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
    Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors.
    Foderà D; D'Alessandro N; Cusimano A; Poma P; Notarbartolo M; Lampiasi N; Montalto G; Cervello M
    Ann N Y Acad Sci; 2004 Dec; 1028():440-9. PubMed ID: 15650269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone augments epirubicin-induced apoptosis in HA22T/VGH cells by increasing oxidative stress and upregulating Fas/FasL.
    Chang WT; Hsieh BS; Cheng HL; Lee KT; Chang KL
    J Surg Res; 2014 May; 188(2):432-41. PubMed ID: 24594218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.
    Feng Z; Fan X; Jiao Y; Ban K
    Hum Pathol; 2011 May; 42(5):659-68. PubMed ID: 21239045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL.
    Emanuele S; D'Anneo A; Bellavia G; Vassallo B; Lauricella M; De Blasio A; Vento R; Tesoriere G
    Eur J Cancer; 2004 Jun; 40(9):1441-52. PubMed ID: 15177505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zanthoxylum avicennae extracts inhibit cell proliferation through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells in vitro and in vivo.
    Dung TD; Chang HC; Binh TV; Lee MR; Tsai CH; Tsai FJ; Kuo WW; Chen LM; Huang CY
    Int J Mol Med; 2012 Jun; 29(6):1045-52. PubMed ID: 22426520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells].
    Chen XL; Wang Q; Cao LQ; Huang XH; Fu XH; Tan HX; Zhen MC; Chen JS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2524-8. PubMed ID: 19080641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
    Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
    Alexia C; Lasfer M; Groyer A
    Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell granules cause proliferation of human microvascular endothelial cells.
    Marks RM; Roche WR; Czerniecki M; Penny R; Nelson DS
    Lab Invest; 1986 Sep; 55(3):289-94. PubMed ID: 2427796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells.
    Pan YY; Xu SP; Jia XY; Xu HQ; Zhang Y; Rui LX; Wei W
    Exp Oncol; 2007 Mar; 29(1):23-9. PubMed ID: 17431384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.